D65
Disseminated intravascular coagulation [defibrination syndrome]
D65 is a billable ICD-10-CM diagnosis code for disseminated intravascular coagulation [defibrination syndrome]. It is part of the FY2027 code set, effective October 1, 2026. The Alphabetic Index lists it under 20 entries. Its coding notes include a Code also instruction, 3 Excludes1 entries and 11 Excludes2 entries.
Code also
Two codes may be needed to describe the condition. This note gives no sequencing order.
- , if applicable, associated condition
Excludes1
Not coded here. The listed conditions generally should not be reported together.
Excludes2
Not included here. Both codes may be reported if the patient has both conditions.
- disseminated intravascular coagulation (complicating):
- abortion or ectopic or molar pregnancy (O00-O07, O08.1)
Also from chapter/block level (9 notes)
- autoimmune disease (systemic) NOS (M35.9)
- certain conditions originating in the perinatal period (P00-P96)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- human immunodeficiency virus [HIV] disease (B20)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Care settings
How CMS programs treat this code. These are CMS claim edits and list entries, not coverage or eligibility rules.
Home Health Primary
Accepted as the primary (principal) diagnosis on a home health claim. The Home Health Grouper assigns it to the MMTA - Infectious Disease, Neoplasms, and Blood-Forming Diseases clinical group.
Source: CMS Home Health Grouper Software v07.2.26, effective October 1, 2026Hospital MCC
Counts as a major complication or comorbidity (MCC) when reported as a secondary diagnosis on an inpatient claim. It does not count when the principal diagnosis is one of the 51 codes in its exclusion list. Some MS-DRGs also ignore a CC or MCC that defines the DRG.
Source: CMS MS-DRG Definitions Manual v44, effective October 1, 2026, Appendix CInclusion terms
Conditions classified to this code.
- Afibrinogenemia, acquired
- Consumption coagulopathy
- COVID-19 associated diffuse or disseminated intravascular coagulopathy
- Diffuse or disseminated intravascular coagulation [DIC]
- Fibrinolytic hemorrhage, acquired
- Fibrinolytic purpura
- Purpura fulminans
Alphabetic Index terms
Terms the official Alphabetic Index lists for this code. 20 entries
- Absence (of) (organ or part) (complete or partial), fibrinogen (congenital), acquired
- Afibrinogenemia, acquired
- Coagulation, intravascular (diffuse) (disseminated), COVID-19 associated
- Coagulopathy, consumption
- Coagulopathy, intravascular
- Defibrination (syndrome)
- Deficiency, deficient, fibrinogen (congenital) (hereditary), acquired
- Disorder (of), glomerular (in), disseminated intravascular coagulation
- Fibrinogenopenia, acquired
- Fibrinolysis (hemorrhagic) (acquired)
- Glomerulonephritis, in (due to), defibrination syndrome
- Glomerulonephritis, in (due to), disseminated intravascular coagulation
Show 8 more
- Hypofibrinogenemia, acquired
- Proteolysis, pathologic
- Purpura, fulminans, fulminous
- Purpura, gangrenous
- Syndrome, DIC (diffuse or disseminated intravascular coagulopathy)
- Syndrome, ICF (intravascular coagulation-fibrinolysis)
- Syndrome, intravascular coagulation-fibrinolysis (ICF)
- Syndrome, IVC (intravascular coagulopathy)